Your browser doesn't support javascript.
loading
Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering.
Krentz, Nicole A J; Shea, Lonnie D; Huising, Mark O; Shaw, James A M.
Affiliation
  • Krentz NAJ; Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
  • Shea LD; Departments of Biomedical Engineering, Chemical Engineering, and Surgery, College of Engineering and School of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Huising MO; Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis, Davis, CA, USA; Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis, Davis, CA, USA.
  • Shaw JAM; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Electronic address: jim.shaw@ncl.ac.uk.
Lancet Diabetes Endocrinol ; 9(10): 708-724, 2021 10.
Article in En | MEDLINE | ID: mdl-34480875
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans / Regenerative Medicine / Diabetes Mellitus, Type 1 Limits: Animals / Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans / Regenerative Medicine / Diabetes Mellitus, Type 1 Limits: Animals / Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2021 Type: Article Affiliation country: United States